期刊文献+

易损斑块标志物和急性冠状动脉综合征 被引量:8

Plasma biomarkers of vulnerable plaque and acute coronary syndrome
下载PDF
导出
摘要 急性冠状动脉综合征(ACS)具有很高的发病率和死亡率,严重威胁人类健康。目前已经证实易损斑块的破裂、血小板聚集和继发血栓形成造成冠状动脉急性严重狭窄或闭塞是ACS的主要发病机制。易损斑块的存在是发生ACS的病理基础,而易损斑块的破裂则是ACS发生的始动环节。早期发现易损斑块,及时进行干预,对降低ACS的发病率和死亡率,具有极其重要的临床意义。血清中一些标记物如C反应蛋白、妊娠相关蛋白A等对易损斑块具有早期诊断价值,有助于早期发现ACS高危人群及将来发生的急性心血管事件。作者就检测易损斑块的标志物的研究进展作一综述。 Patients with acute coronary syndromes have a high morbidity and mortality rates, which is a serious health problem. Now it has been confirmed that rupture or erosion of the vulnerable plaque, platelet aggregation and thrombogenesis in the coronary artery is the main pathogenesy of ACS. Vulnerable plaque in coronary artery is the primary pathological basis of ACS. Plaque rupture is the initiating factor of ACS. So it has important clinical significance to find the vulnerable plaques early and take some necessary measures to intervene it for decreasing the morbidity and mortality rates of the patients with ACS. Some plasma biomarkers have been believed the markers of the vulnerable plaques and used to predict the high risk patients and future cardiovascular events in patients with ACS,including high sensitiventy C-reactive protein and pregnancy associated plasma protein-A, etal. This article reviews the new development of the plasma biomarkers of the vulnerable plaque.
出处 《新乡医学院学报》 CAS 2007年第6期632-635,共4页 Journal of Xinxiang Medical University
关键词 易损斑块 血清标记物 急性冠状动脉综合征 vulnerable plaque plasma markers acute coronary syndrome
  • 相关文献

参考文献24

  • 1Ridker PM.Creactive protein:A simple test to help predict risk of heart attack and stroke[J].Circulation,2003,108(12):e81-e85.
  • 2Ohlmann P,Morel O,Jaquemin LEI,et al.Prognostic value of C-reactive protein and cardiac troponin l in primary percutaneous interventions for STelevation myocardial infarction[J].Am Heart J,2006,152(6):1161-1167.
  • 3Danesh J,Wheeler JG,Hirshfield GM,et al.C-reactive protein and other circulatory markers of inflammation in the prediction of coronary heart disease[J].N Engl J Med,2004,350:1387-1397.
  • 4Biasucci LM,CDC,AHA.CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice:clinical use of inflammatory markers in patients with cardiovascular diseases:a background paper[J].Circulation,2004,110(25):e560-e567.
  • 5李华.血浆纤维蛋白原与急性冠脉综合征的相关性研究[J].医学信息(西安上半月),2006,19(5):867-868. 被引量:4
  • 6Armstrong EJ,Morrow DA,Sabatine MS.Inflammatory biomarkers in acute coronary syndromes:Part I:introduction and cytokines[J].Circulation,2006,113(6):e72-e75.
  • 7Ridker PM,Hennekens CH,Buring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [J].N Eng J Med,2000,342(12):836-843.
  • 8Bayes-Genis A,Conover CA,Overgaard MT,et al.Pregnancy-Associated plasma protein A as a marker of acute coronary syndromes[J].N Engl J Med,2001,345(14):1022-1029.
  • 9Lund J,Qin QP,Ilva T,et al.Circulating pregnancy-associated plasma protein-A predicts outcome in patients with acute coronary syndrome but no troponin I elevation[J].Circulation,2003,108(16):1924-1926.
  • 10Elesber AA,Conover CA,Denktas AE,et al.Prognostic value of circulating pregnancy-associated plasma protein-A levels in patients with chronic stable angina[J].Eur Heart J,2006,27(14):1678-1684.

二级参考文献19

  • 1黄维义,彭永权,石娟,邓辉胜,李刚,莫余波.支架置入术后血清C反应蛋白浓度与血红素氧合酶-1活性变化及意义[J].临床心血管病杂志,2004,20(12):720-722. 被引量:4
  • 2Minno GD,Mancini M,Measuring plasma fibrinogen to predict stoke and myocardial infarction[J].Ateriosclerosis,2001,10.1-7.
  • 3Friedl w,Ludwig EH,Pawlweber B,et al.Hypervariability in a minisate vites of the apolipoprotein B gene in patients with coronary heart disease compareel with normal controls[J].J Lipid Res,2002,31:651-665.
  • 4Levenson J,Giral P,Razavian M,et al.Fibrinogen and silent atheros clerosis in subjects with cardiovascular risk factors[J].Arteriosder Thromb Vasc Biol.2003,15:1263-1268.
  • 5Maresca G,Blasio AD,Marchiolir R,et al.Measuring plasma fibrinogen to predict stoke and myocardial infarction an update[J].Arterioscler Thromb Vascbiol,2002.19.1368-1377.
  • 6Yarnell JWG,Baker IA,Sweetnam PM,et al.Fibrinogeen Viscosity,and white blood cell count are major risk factors for ischemic heart disease.Thecaerphilg and speedwell collaborative heart stndies[J].Circulation.2003,83:836-844.
  • 7Blake GJ,Schmitz C,Lindpaintnerk,et al.Mutation in the promoter region of the beta-fibbrinogen gene and the risk of future myocardial infaction,stoke and renous thrombosis[J].Eur Heart J,2001,22(24):2262-2266.
  • 8BAYES-GENIS A,CONOVER C A,SCHWARTZ R S.The insulin-like growth factor axis,a review of atherosclerosis and restenosis[J].Circ Res,2000,86:125-125.
  • 9JEONG W K,JEONG M H,KIM K H,et al.An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention.Korean[J].J Intern Med,2003,18:154-160.
  • 10VERSACI F,GASPARDONE A,TOMAI F,et al.Predictive value of C reactive protein in patients with unstable angina pectoris under going coronary artery stent implantantion[J].Am J Cardiol,2000,85:92-95.

共引文献16

同被引文献102

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部